Lynparza 150 mg Alternative – Olapar (Olaparib) 150 mg Tablet | Beacon Pharmaceuticals

Product Overview

Olapar 150 mg Tablet is listed in the supplied Beacon Pharmaceuticals anti-cancer and hematology price list. The stated active ingredient is Olaparib. Lynparza is a reference brand for the generic ingredient. This is a product-identification comparison, not a claim of verified bioequivalence or interchangeability.

Olapar vs Lynparza – Reference Brand Comparison

Lynparza is a recognized reference brand associated with Olaparib. Olapar is listed under Beacon Pharmaceuticals. Their excipients, marketing authorizations, formulation details and regulatory evidence may differ. A clinician or pharmacist must confirm whether substitution is appropriate.

Composition and Active Ingredient

Brand: Olapar. Active ingredient: Olaparib. Strength: 150 mg. Dosage form: Tablet. Therapeutic class: PARP inhibitor. Listed manufacturer: Beacon Pharmaceuticals Ltd., Bangladesh. Packaging details should be confirmed on the manufacturer’s current pack.

Therapeutic Uses and Indications

Olaparib is used in selected ovarian, breast, pancreatic and prostate cancers. These are generic-level clinical contexts and do not independently confirm every indication for this particular branded presentation. Eligibility may depend on biomarkers, previous therapy and country-specific labeling.

Mechanism of Action – How Olaparib Works

Olaparib impairs PARP-mediated DNA repair. This mechanism alone does not establish suitability or effectiveness for an individual patient.

Dosage and Administration

The 150 mg shown is the strength of this tablet, not a recommended daily dose. Dose, timing, food instructions and treatment duration must be determined by the treating specialist using the current authorized prescribing information. Do not change dose or substitute brands or strengths without medical approval.

Contraindications

Contraindications depend on Olaparib, formulation and individual medical conditions. Review the current official prescribing information, particularly hypersensitivity, pregnancy-related and organ-function restrictions.

Warnings and Precautions

Important safety considerations include anemia, nausea and rare marrow disorders. The prescriber may require laboratory testing, cardiac or organ-function assessment, and ongoing monitoring.

Possible Side Effects

Potential adverse effects and serious reactions include anemia, nausea and rare marrow disorders. Other reactions can occur. Consult the product leaflet for the full adverse-effect profile and seek medical care for severe symptoms.

Drug Interactions

Drug interactions may affect treatment effectiveness or toxicity. Inform the treating clinician of all prescriptions, over-the-counter products, herbal supplements and other treatments.

Pregnancy, Fertility and Breastfeeding

Some oncology and hematology medicines can cause fetal harm and require specific contraception or breastfeeding restrictions. Follow the medicine-specific official labeling and specialist advice.

Storage and Handling

Store according to the instructions printed on the actual Beacon Pharmaceuticals pack. Protect from inappropriate heat, humidity and light, and keep out of reach of children. Do not assume the storage conditions of another brand apply.

Why Is Olapar Listed as an Alternative to Lynparza?

The comparison helps identify another listed brand containing Olaparib. It does not establish identical formulation, regulatory approval, bioequivalence or permission to substitute.

Manufacturer Information

Listed brand: Olapar. Manufacturer: Beacon Pharmaceuticals Ltd., Bangladesh. Reference brand: Lynparza. Generic: Olaparib. Strength: 150 mg. Dosage form: Tablet.

Frequently Asked Questions

What is Olapar 150 mg? It is a tablet containing Olaparib 150 mg according to the supplied Beacon price list. What is it used for? Olaparib is used in selected ovarian, breast, pancreatic and prostate cancers, subject to specialist assessment. Can it replace Lynparza? Not automatically; a qualified professional must check product-specific equivalence and regulatory requirements. Is a prescription required? Yes, appropriate prescription and specialist supervision are necessary.

Important Medical Disclaimer

This listing is for educational pharmaceutical identification only and is not a substitute for medical advice, official product labeling or regulatory review. Brand, strength and pack details should be confirmed against the current manufacturer information before dispensing.